Canadian licensed producer (LP) Aurora Cannabis (TSX:ACB; NYSE:ACB) kickstarted the week with two hefty announcements on Monday (November 5). 

The cannabis giant announced that it has officially opened its indoor premium cannabis production facility in Quebec, in addition to increasing its investment in cannabis retailer, Choom (CSE:CHOO) through a non-brokered private placement.

As a result of two announcements on Monday, the company’s shares on the Toronto Stock Exchange increased by 3.91 percent to close the trading session at C$9.56.

Aurora’s newest production facility, called Aurora Eau, is located in Lachute, Quebec and spans 48,000 square feet. The facility is comprised of 11 purpose-built grow rooms, which will allow the facility to produce up to 4,500 kg of cannabis annually.

This is Aurora Cannabis’ second production facility in Quebec, with the first one being Aurora Vie, an indoor growing facility in Point Claire.

Terry Booth, CEO of Aurora Cannabis, said the company is “thrilled” with its latest facility and looks forward to continue investing in Quebec. He noted that the Aurora Eau facility, in particular, has “incredible potential.”

“[Aurora Eau is] designed to be a place where our expert cannabis cultivators have the flexibility and control to produce some very special high-end varieties that few commercial growers are prepared to tackle. We intend to make some very rare and exciting products there,” Booth said in the release.

That said, the company also increased its investment in Choom Holdings by an additional C$20 million, which translates to a conversion price of C$1.25 per common share with a four year maturity date.  Aurora has also been granted the opportunity to acquire up to 40 percent in Choom at C$2.75 per common share.

“Through this strategic investment, Aurora further diversifies its retail strategy, with additional retail opportunities across Western Canada, and future potential opportunities in the Ontario market,” Booth said in the release. “We are pleased to increase our stake in Choom and support them as they execute on introducing their unique retail brand to Canadian cannabis consumers.”

US Election 2020 and Cannabis

Investing in cannabis? Read what experts have to say about cannabis and the US Election!

According to the release, Choom is in the process of developing a network of retail stores that will feature selected products from a variety of LPs.  It has secured the rights to 45 retail opportunities within Western Canada. This includes 45 applications submitted, with 27 of those as development permits and the remaining 18 as building permits.

Thanks to the investment from Aurora, Choom plans continue expanding in the retail Canadian cannabis adult market.  Choom plans to use the proceeds for working capital and general corporate reasons.

“Aurora’s continued confidence and investment allows Choom to provide high quality cannabis to a broader market of consumers across the entire country and expedite our expansion and the roll out of store openings,” Chris Bogart, president and CEO of Choom, said in the release.

Shares of Choom, however, took a dip on the Canadian Securities Exchange following the announcement on Monday. As of market close, Choom’s stock dipped to C$0.89, which is a 3.26 percent decrease over Monday’s trading period.

Don’t forget to follow us @INN_Cannabis for real-time news updates!

Securities Disclosure: I, Jocelyn Aspa, hold no direct investment interest in any company mentioned in this article.

Pawar Law Group announces that a class action lawsuit has been filed on behalf of shareholders who purchased shares of Aurora Cannabis Inc. (NYSE: ACB) from February 13, 2020 through September 4, 2020, inclusive (the “Class Period”). The lawsuit seeks to recover damages for Aurora Cannabis Inc. investors under the federal securities laws.

To join the class action, go here or call Vik Pawar, Esq. toll-free at 888-589-9804 or email for information on the class action.

Keep reading... Show less

The Israeli cannabis market is picking up with a new supply deal from a Canadian producer.

Also this week, new data showed sales of Canadian cannabis edible products may be stalling.

Keep reading... Show less

The Israeli cannabis market is picking up as a Canadian producer announced a new supply deal in the country.

Also this week it was shown the sales of Canadian cannabis edible products may be stalling, according to new data.

Keep reading... Show less

The Portnoy Law Firm advises investors that class action lawsuits have been filed on behalf of investors in the following publicly traded companies. Shareholders interested in taking an active role in these cases have until the deadlines indicated below to petition the court. There is no cost or obligation to you. See below for more information on these cases.

Credit Acceptance Corporation investors (NASDAQ: CACC); December 1, 2020 deadline, click here to join .

Keep reading... Show less
  • On November 19 , the Mexican Senate passed comprehensive adult-use cannabis legalization, moving Mexico towards becoming one of the few countries to legalize cannabis nationally
  • On March 31, 2020 , the Company entered into an agreement with Tecnologico de Monterrey , the leading university in Mexico , to educate physicians across Latin America , in advance of the impending regulations in Mexico
  • To date, close to 550 LatAm physicians have obtained their diploma accrediting completion of Khiron’s medical education program
  • The Company plans to deploy its ZereniaTM medical cannabis clinics and telehealth strategy in Mexico , building on the success of its vertical integration strategy in Colombia
  • Expanding the Zerenia clinic strategy will build on the Company’s Colombia knowledge and proven distribution capabilities, with rapid telehealth service adoption and over 5,600 medical cannabis scripts filled to date
  • Mexico represents one of the largest potential markets for medical cannabis in the world and is anticipated to reach $1.2bn USD by 2028 (Prohibition Partners).
  • Company to release Q3 2020 financials and host webcast on Tuesday, December 1st

Khiron Life Sciences Corp. (“Khiron” or the “Company”) (TSXV: KHRN ), (OTCQX: KHRNF), ( Frankfurt : A2JMZC), a vertically integrated cannabis leader with core operations in Latin America and Europe welcomes the passing of adult-use cannabis legislation by the Mexican Senate, which moves the country closer to a legalized cannabis market, and towards provision for medical cannabis products.  Khiron has had a presence in Mexico since 2018 and has been working with doctors and medical institutions to develop a deep understanding of the market.

Keep reading... Show less